HomeIDXG • OTCMKTS
add
Interpace Biosciences Inc
Previous close
$0.62
Day range
$0.57 - $0.99
Year range
$0.52 - $3.54
Market cap
4.23M USD
Avg Volume
20.41K
P/E ratio
0.90
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 12.30M | 35.44% |
Operating expense | 5.60M | 12.70% |
Net income | 1.28M | 308.47% |
Net profit margin | 10.41 | 253.99% |
Earnings per share | — | — |
EBITDA | 1.99M | 788.84% |
Effective tax rate | 0.29% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.11M | -58.01% |
Total assets | 14.04M | -1.48% |
Total liabilities | 25.18M | -17.14% |
Total equity | -11.15M | — |
Shares outstanding | 4.40M | — |
Price to book | -0.05 | — |
Return on assets | 35.26% | — |
Return on capital | -118.10% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 1.28M | 308.47% |
Cash from operations | 2.12M | 91.49% |
Cash from investing | -522.00K | -250.00% |
Cash from financing | -1.50M | 0.00% |
Net change in cash | 94.00K | 300.00% |
Free cash flow | 852.00K | -56.84% |
About
Founded
1986
Headquarters
Website
Employees
108
